Normalized (to CTDIfree-in-air) Maternal Organ and Embryo/Fetal Dose Data for Pregnant Patients Subjected to CTPA Exposure at 100 kV
| Gestational stage (mo) | ||||
| Parameter | 0 | 3 | 6 | 9 |
| BMI (kg/m2) | 19.7/22.9/26.3 | 19.7/22.9/26.3 | 19.7/22.9/26.3 | 19.7/22.9/26.3 |
| Site | ||||
| Breast | 0.510/0.467/0.433 | 0.510/0.467/0.433 | 0.511/0.467/0.433 | 0.511/0.467/0.433 |
| Colon | 0.006/0.005/0.004 | 0.006/0.005/0.004 | 0.006/0.005/0.004 | 0.006/0.005/0.004 |
| Lung | 0.531/0.447/0.373 | 0.531/0.448/0.373 | 0.580/0.483/0.398 | 0.583/0.488/0.407 |
| Red bone marrow | 0.140/0.115/0.092 | 0.139/0.113/0.089 | 0.136/0.111/0.086 | 0.137/0.110/0.085 |
| Stomach | 0.077/0.070/0.063 | 0.080/0.073/0.071 | 0.097/0.087/0.074 | 0.093/0.084/0.076 |
| Gonads | 0.010/0.008/0.006 | 0.009/0.008/0.006 | 0.009/0.007/0.006 | 0.010/0.008/0.006 |
| Bladder | 0.009/0.007/0.005 | 0.009/0.006/0.005 | 0.009/0.006/0.005 | 0.009/0.006/0.005 |
| Esophagus | 0.323/0.266/0.217 | 0.322/0.265/0.217 | 0.327/0.267/0.217 | 0.342/0.270/0.222 |
| Liver | 0.108/0.098/0.088 | 0.108/0.099/0.088 | 0.140/0.124/0.108 | 0.140/0.124/0.108 |
| Thyroid | 0.156/0.141/0.125 | 0.155/0.140/0.123 | 0.160/0.141//0.126 | 0.158/0.142/0.127 |
| Bone | 0.270/0.221/0.177 | 0.268/0.217/0.171 | 0.267/0.214/0.167 | 0.265/0.212/0.163 |
| Brain | 0.018/0.018/0.018 | 0.018/0.018/0.018 | 0.018/0.018/0.018 | 0.018/0.018/0.018 |
| Salivary glands | 0.021/0.022/0.021 | 0.021/0.021/0.022 | 0.021/0.021/0.021 | 0.021/0.021/0.021 |
| Skin | 0.084/0.080/0.077 | 0.085/0.080/0.078 | 0.083/0.079/0.076 | 0.083/0.078/0.075 |
| Remainder | 0.131/0.116/0.101 | 0.132/0.117/0.101 | 0.136/0.120/0.103 | 0.140/0.124/0.107 |
| Maternal effective dose | 0.19/0.16/0.14 | 0.19/0.17/0.15 | 0.20/0.17/0.15 | 0.20/0.17/0.15 |
| Embryo/fetal dose | 0.010/0.008/0.007 | 0.012/0.010/0.008 | 0.012/0.011/0.011 | 0.012/0.012/0.012 |